Bioxytran annual capital expenditures (capex)
2021
2022
2023
2024
2025
Bioxytran Capital Expenditures (CapEx) Growth & History (BIXT)
Bioxytran's capital expenditures (capex) was $23,091 for fiscal 2025.
View full Bioxytran company overviewBioxytran annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $23,091 | −$5,103 | −18.10% |
| 2024 | 2024-12-31 | $28,194 | −$16,107 | −36.36% |
| 2023 | 2023-12-31 | $44,301 | $12,054 | +37.38% |
| 2022 | 2022-12-31 | $32,247 | −$4,684 | −12.68% |
| 2021 | 2021-12-31 | $36,931 | — | — |
Bioxytran quarterly capital expenditures (capex)
Q3.13
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9,383 | −$3,270 | −25.84% |
| Q1 2026 | 2026-03-31 | $9,227 | $9,212 | +61413.33% |
| Q4 2025 | 2025-12-31 | $6,240 | −$5,831 | −48.31% |
| Q3 2025 | 2025-09-30 | $4,183 | −$6,638 | −61.34% |
| Q2 2025 | 2025-06-30 | $12,653 | $11,960 | +1725.83% |
| Q1 2025 | 2025-03-31 | $15 | −$5,980 | −99.75% |
| Q4 2024 | 2024-12-31 | $12,071 | $5,510 | +83.98% |
| Q3 2024 | 2024-09-30 | $10,821 | −$1,872 | −14.75% |
| Q2 2024 | 2024-06-30 | $693 | −$19,643 | −96.59% |
| Q1 2024 | 2024-03-31 | $5,995 | $1,284 | +27.26% |
| Q4 2023 | 2023-12-31 | $6,561 | $4,465 | +213.02% |
| Q3 2023 | 2023-09-30 | $12,693 | $4,980 | +64.57% |
| Q2 2023 | 2023-06-30 | $20,336 | $20,221 | +17583.48% |
| Q1 2023 | 2023-03-31 | $4,711 | −$17,612 | −78.90% |
| Q4 2022 | 2022-12-31 | $2,096 | — | — |
| Q3 2022 | 2022-09-30 | $7,713 | $7,713 | — |
| Q2 2022 | 2022-06-30 | $115 | — | — |
| Q1 2022 | 2022-03-31 | $22,323 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q3 2013 | 2013-09-30 | $10,184 | — | — |
Bioxytran capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioxytran's capital expenditures (capex) decreased from $36,931 to $23,091, a change of −$13,840. The latest reported quarter, Q2 2026, shows $9,383.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioxytran source filings ↗